IL Healthcare Equipment & Supplies

Inspira Technologies Oxy BHN Ltd (IINN)

Track

Inspira Technologies Oxy BHN Ltd experienced significant insider trading activity recently, with executives offloading over $1 million in shares. CFO Tehila Yafit and other officers executed multiple planned or proposed sales. Despite a 238.4% stock price surge over ninety days, no buying occurred. These divestments coincide with high volatility before any upcoming results financiers.
Ticker: IINN Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Tehila Yafit Chief Financial Officer Officer
Transaction date
Planned sale
Price
57.11
Quantity 51,225 +5.4%
Value US$4,065,983
Tehila Yafit Officer Officer
Transaction date
Proposed sale
Price
22.38
Quantity 59,908
Value US$2,025,843
Tehila Yafit Chief Financial Officer Officer
Transaction date
Planned sale
Price
129.80
Quantity 70,913 +37.2%
Value US$639,760
Yechezkely Hayon Daniella Chief Technology Officer Officer
Transaction date
Sale
Price
3.00
Quantity 50,000 -6.0%
Value US$150,000
Yechezkely Hayon Daniella Officer Officer
Transaction date
Proposed sale
Price
3.00
Quantity 50,000
Value US$150,000
shabtay abraham Officer Officer
Transaction date
Proposed sale
Price
3.00
Quantity 95,239
Value US$285,717
Tehila Yafit Officer Officer
Transaction date
Proposed sale
Price
3.00
Quantity 10,000
Value US$30,000
Tehila Yafit Chief Financial Officer Officer
Transaction date
Planned sale
Price
3.00
Quantity 15,000 -1.6%
Value US$45,000
Tehila Yafit Chief Financial Officer Officer
Transaction date
Planned sale
Price
2.56
Quantity 15,000 -1.6%
Value US$38,400
Tehila Yafit Officer Officer
Transaction date
Proposed sale
Price
2.10
Quantity 30,000
Value US$63,000
Tehila Yafit Chief Financial Officer Officer
Transaction date
Planned sale
Price
2.01
Quantity 16,395 -1.7%
Value US$33,010
Tehila Yafit Chief Financial Officer Officer
Transaction date
Planned sale
Price
2.03
Quantity 13,605 -1.4%
Value US$27,551
Tehila Yafit Officer Officer
Transaction date
Proposed sale
Price
1.52
Quantity 30,000
Value US$45,600
Rozen Limor Director Non-Executive Director
Transaction date
Proposed sale
Price
0.89
Quantity 4,701
Value US$4,184
Rozen Limor Director Non-Executive Director
Transaction date
Proposed sale
Price
1.03
Quantity 10,730
Value US$11,052
Rozen Limor Director Non-Executive Director
Transaction date
Proposed sale
Price
1.13
Quantity 14,999
Value US$16,949
Goldwasser Benad Director Non-Executive Director
Transaction date
Proposed sale
Price
0.74
Quantity 35,270
Value US$26,234
Goldwasser Benad Director Non-Executive Director
Transaction date
Proposed sale
Price
0.77
Quantity 81,633
Value US$62,613
Goldwasser Benad Director Non-Executive Director
Transaction date
Proposed sale
Price
1.00
Quantity 35,271
Value US$35,151
Goldwasser Benad Director Non-Executive Director
Transaction date
Proposed sale
Price
1.18
Quantity 43,808
Value US$51,693
shabtay abraham Officer Officer
Transaction date
Proposed sale
Price
2.08
Quantity 19,048
Value US$39,620
Amit Lior Director Non-Executive Director
Transaction date
Proposed sale
Price
2.31
Quantity 834
Value US$1,927
Amit Lior Director Non-Executive Director
Transaction date
Proposed sale
Price
1.98
Quantity 21,967
Value US$43,495
Amit Lior Director Non-Executive Director
Transaction date
Proposed sale
Price
1.95
Quantity 5,532
Value US$10,787
Goldwasser Benad Officer Officer
Transaction date
Proposed sale
Price
1.34
Quantity 35,270
Value US$47,332
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-02 2026-06-01 PlS Planned sale
Tehila Yafit

Chief Financial Officer

Officer
51,225 +5.4%
57.11
US$4,065,983 		51,225 +5.4% 57.11 US$4,065,983
2026-06-01 2026-06-01 PrS Proposed sale
Tehila Yafit

Officer

Officer
59,908
22.38
US$2,025,843 		59,908 22.38 US$2,025,843
2026-06-02 2026-05-29 PlS Planned sale
Tehila Yafit

Chief Financial Officer

Officer
70,913 +37.2%
129.80
US$639,760 		70,913 +37.2% 129.80 US$639,760
2026-06-02 2026-05-29 S Sale
Yechezkely Hayon Daniella

Chief Technology Officer

Officer
50,000 -6.0%
3.00
US$150,000 		50,000 -6.0% 3.00 US$150,000
2026-06-01 2026-05-29 PrS Proposed sale
Yechezkely Hayon Daniella

Officer

Officer
50,000
3.00
US$150,000 		50,000 3.00 US$150,000
2026-06-01 2026-05-29 PrS Proposed sale
shabtay abraham

Officer

Officer
95,239
3.00
US$285,717 		95,239 3.00 US$285,717
2026-06-01 2026-05-29 PrS Proposed sale
Tehila Yafit

Officer

Officer
10,000
3.00
US$30,000 		10,000 3.00 US$30,000
2026-05-29 2026-05-28 PlS Planned sale
Tehila Yafit

Chief Financial Officer

Officer
15,000 -1.6%
3.00
US$45,000 		15,000 -1.6% 3.00 US$45,000
2026-05-29 2026-05-28 PlS Planned sale
Tehila Yafit

Chief Financial Officer

Officer
15,000 -1.6%
2.56
US$38,400 		15,000 -1.6% 2.56 US$38,400
2026-05-29 2026-05-28 PrS Proposed sale
Tehila Yafit

Officer

Officer
30,000
2.10
US$63,000 		30,000 2.10 US$63,000
2026-05-29 2026-05-27 PlS Planned sale
Tehila Yafit

Chief Financial Officer

Officer
16,395 -1.7%
2.01
US$33,010 		16,395 -1.7% 2.01 US$33,010
2026-05-29 2026-05-27 PlS Planned sale
Tehila Yafit

Chief Financial Officer

Officer
13,605 -1.4%
2.03
US$27,551 		13,605 -1.4% 2.03 US$27,551
2026-05-28 2026-05-27 PrS Proposed sale
Tehila Yafit

Officer

Officer
30,000
1.52
US$45,600 		30,000 1.52 US$45,600
2026-01-16 2026-01-15 PrS Proposed sale
Rozen Limor

Director

Non-Executive Director
4,701
0.89
US$4,184 		4,701 0.89 US$4,184
2025-11-13 2025-11-12 PrS Proposed sale
Rozen Limor

Director

Non-Executive Director
10,730
1.03
US$11,052 		10,730 1.03 US$11,052
2025-10-23 2025-10-22 PrS Proposed sale
Rozen Limor

Director

Non-Executive Director
14,999
1.13
US$16,949 		14,999 1.13 US$16,949
2025-03-19 2025-03-19 PrS Proposed sale
Goldwasser Benad

Director

Non-Executive Director
35,270
0.74
US$26,234 		35,270 0.74 US$26,234
2025-03-14 2025-03-13 PrS Proposed sale
Goldwasser Benad

Director

Non-Executive Director
81,633
0.77
US$62,613 		81,633 0.77 US$62,613
2024-12-19 2024-12-19 PrS Proposed sale
Goldwasser Benad

Director

Non-Executive Director
35,271
1.00
US$35,151 		35,271 1.00 US$35,151
2024-08-26 2024-08-26 PrS Proposed sale
Goldwasser Benad

Director

Non-Executive Director
43,808
1.18
US$51,693 		43,808 1.18 US$51,693
2024-06-11 2024-06-10 PrS Proposed sale
shabtay abraham

Officer

Officer
19,048
2.08
US$39,620 		19,048 2.08 US$39,620
2024-05-20 2024-05-17 PrS Proposed sale
Amit Lior

Director

Non-Executive Director
834
2.31
US$1,927 		834 2.31 US$1,927
2024-05-06 2024-05-03 PrS Proposed sale
Amit Lior

Director

Non-Executive Director
21,967
1.98
US$43,495 		21,967 1.98 US$43,495
2024-05-03 2024-05-02 PrS Proposed sale
Amit Lior

Director

Non-Executive Director
5,532
1.95
US$10,787 		5,532 1.95 US$10,787
2023-04-17 2023-04-17 PrS Proposed sale
Goldwasser Benad

Officer

Officer
35,270
1.34
US$47,332 		35,270 1.34 US$47,332
Explore more

More insider trading research around Inspira Technologies Oxy BHN Ltd

More insider trades in IL
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity